Association of combined CYP2E1 gene polymorphism with the risk for esophageal squamous cell carcinoma in Huai'an population, China

Chinese Medical Journal

Volumn 120, Issue 20, 2007, Pages 1797-1802

  Liu, Ran ^a   Yin, Li Hong ^a   Pu, Yue Pu ^a  

^a SOUTHEAST UNIVERSITY   (China)

Author keywords

Cytochrome P450 2E1; Esophageal neoplasms; Polymorphism; Single nucleotide

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 2E1; MESSENGER RNA; PROTEIN DRAI; PROTEIN RSAI; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CHINA; CONTROLLED STUDY; DNA FLANKING REGION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 36148990260     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200710020-00013     Document Type: Article

References (22)

1. Krovat BC, Tracy JH, Omiecinski CJ. Fingerprinting of cytochrome P450 and microsomal epoxide hydrolase gene expression in human blood cells. Toxicol Sci 2000; 55: 352-360.
2. Nishimura M, Yaguti H, Yoshitsugu H, Naito S, Satoh T. Tissue distribution of mRNA expression of human cytochrome P450 isoforms assessed by high-sensitivity real time reverse transcription PCR. Yakugaku Zasshi 2003; 123: 369-375.
3. Godoy W, Albano RM, Moraes EG, Pinho PR, Nunes RA, Saito EH, et al. CYP2A6/2A7 and CYP2E1 expression in human oesophageal mucosa: regional and inter-individual variation in expression and relevance to nitrosamine metabolism. Carcinogenesis 2002; 23: 611-616.
4. Zhu J, He Z, Wang S, Chen Z. Effect of N,N'-dinitrosopiperazine on in vitro expression of humancytochrome P450 2E1. Chin Med J 2002; 115: 1229-1232.
5. Hayashi S, Watanabe J, Kawajiri K. Genetic polymorphisms in the 5′-flanking region change transcriptional regulation of the human cytochrome P450 IIE1 gene. J Biochem (Tokyo) 1991; 110: 559-565.
6. Watanabe J, Hayashi SI, Kawajiri K. Different regulation and expression of the human CYP2E1 gene due to the Rsal polymorphism in the 5′-flanking region. J Biochem (Tokyo) 1994; 116: 321-326.
7. Tan W, Wu JX, Tang KJ, Lin DJ. Expression of cytochrome P4502E1 in human liver: relationship between genotype and phenotype in Chinese. Sci China C Life Sci 2001; 31: 22-30.
8. Marchand LL, Wilkinson GR, Wilkens LR. Genetic and dietary predictors of CYP2E1 activity: a phenotyping study in Hawaii Japanese using Chlorzoxazone. Cancer Epidemiol Biomarkers Prev 1999; 8: 495-500.
9. Bartsch H, Nair U, Risch A, Rojas M, Wikman H, Alexandrov K. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev 2000; 9: 3-28.
10. Wu X, Amos CI, Kemp BL, Shi H, Jiang H, Wan Y, et al. Cytochrome P450 2E1 Dral polymorphisms in lung cancer in minority populations. Cancer Epidemiol Biomarkers Prev 1998; 7:13-18.
11. Verlaan M, Te Morsche RH, Roelofs HM, Laheij RJ, Jansen JB, Peters WH, et al. Genetic polymorphisms in alcohol-metabolizing enzymes and chronic pancreatitis. Alcohol 2004; 39: 20-24.
12. -ΔΔCT method. Methods 2001; 25: 402-408.
13. Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005; 15: 97-98.
14. Gao C, Takezaki T, Wu J, Li Z, Wang J, Ding J, et al. Interaction between cytochrome P-450 2E1 polymorphisms and environmental factors with risk of esophageal and stomach cancers in Chinese. Cancer Epidemiol Biomarkers Prev 2002; 11: 29-34.
15. Wang W, Shi RH, Zhao ZQ. Impact of CYP2E1 polymorphisms on the risk of esophageal cancer. Acta Acad Med Nanjing (Chin) 2004; 24: 344-347.
16. Stephens EA, Taylor JA, Kaplan N, Yang CH, Hsieh LL, Lucier GW, et al. Ethnic variation in the CYP2E1 gene: polymorphism analysis of 695 Africa-Americans, European-Americans and Taiwanese. Pharmacogenetics 1994; 4: 185-192.
17. Wang J, Deng Y, Li L, Kuriki K, Ding J, Pan X, et al. Association of GSTM1, CYP1A1 and CYP2E1 genetic polymorphisms with susceptibility to lung adenocarcinoma: a case-control study in Chinese population. Cancer Sci 2003; 94: 448-452.
18. Morita S, Yano M, Shiozaki H, Tsujinaka T, Ebisui C, Morimoto T, et al. CYP1A1, CYP2E1 and GSTM1 polymorphisms are not associated with susceptibility to squamous-cell carcinoma of the esophagus. Int J Cancer 1997; 71: 192-195.
19. Lucas D, Menez C, Floch F, Gourlaouen Y, Sparfel O, Joannet I, et al. Cytochromes P4502E1 and P4501A1 genotypes and susceptibility to cirrhosis or upper aerodigestive tract cancer in alcoholic caucasians. Alcohol Clin Exp Res 1996; 20: 1033-1037.
20. Tan W, Song N, Wang GQ, Liu Q, Tang HJ, Kadlubar FF, et al. Impact of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferases M1, T1, and P1 on susceptibility to esophageal cancer among high-risk individuals in China. Cancer Epidemiol Biomarkers Prev 2000; 9: 551-556.
21. Kim RB, Yamazaki H, Chiba K, O'Shea D, Mimura M, Geungerieh FP, et al. In vivo and in vitro characterization of CYP2E1 activity in Japanese and Caucasians. J Pharmacol Exp Ther 1996; 279: 4-11.
22. Kim RB, O'Shea D. Interindividual variability of chlorzoxazone 6-hydroxylation in men and women and its relationship to CYP2E1 genetic polymorphisms. Clin Pharmacol Ther 1995; 57: 645-655.